MedTech Dive January 25, 2024
The reorganization establishes new divisions at the Office of Strategic Partnerships and Technology Innovation to account for its growth since 2019.
Dive Brief:
- The Food and Drug Administration has elevated and expanded an office that handles activities including medical device cybersecurity and digital health.
- Effective immediately, the Office of Strategic Partnerships and Technology Innovation (OST) has become a “super office.” The reorganization creates new divisions and programs at the OST to account for its growth since 2019 and raise the profile of digital health work.
- The five offices housed in the OST will lead the FDA’s medical device resilient supply chain and shortages program, drive the development of voluntary consensus standards and work on new approaches to digital health...
Today's Sponsors
Today's Sponsor